Core Viewpoint - Meikang Bio (300439.SZ) has received a medical device registration certificate for its Heparin-Binding Protein Test Kit, enhancing its product line in the in vitro diagnostic sector and positively impacting future operations [1] Group 1 - Meikang Bio's subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., obtained the registration certificate from the Jiangxi Provincial Drug Administration [1] - The product, Heparin-Binding Protein Test Kit, utilizes chemiluminescent immunoassay technology [1] - The acquisition of this certificate enriches the company's offerings in the in vitro diagnostic field, improving its core competitiveness and market expansion capabilities [1]